Importance of codon usage for the temporal regulation of viral gene expression

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 45, 2015, Pages 14030-14035

  Shin, Young C ^a   Bischof, Georg F ^a,b   Lauer, William A ^a   Desrosiers, Ronald C ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 160; REV PROTEIN; VIRUS RNA; CODON; COMPLEMENTARY DNA; LUCIFERASE; PRIMER DNA; VIRAL PROTEIN;

CODON USAGE; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE PRODUCT; GENE SEQUENCE; GENETIC TRANSFECTION; HERPESVIRIDAE; LUCIFERASE ASSAY; NONHUMAN; PRIORITY JOURNAL; RNA STRUCTURE; SIMIAN IMMUNODEFICIENCY VIRUS; START CODON; STRUCTURAL GENE; VIRUS GENE; CODON; GENETICS; HEK293 CELL LINE; HUMAN; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PLASMID; SEQUENCE ALIGNMENT; SPECIES DIFFERENCE; TIME FACTOR;

BASE SEQUENCE; CODON; DNA PRIMERS; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION, VIRAL; HEK293 CELLS; HUMANS; LUCIFERASES; MOLECULAR SEQUENCE DATA; PLASMIDS; SEQUENCE ALIGNMENT; SPECIES SPECIFICITY; TIME FACTORS; VIRAL REGULATORY AND ACCESSORY PROTEINS;

EID: 84946781152     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1515387112     Document Type: Article

References (47)

1. Damania B, et al. (2004) Comparison of the Rta/Orf50 transactivator proteins of gamma-2-herpesviruses. J Virol 78(10):5491-5499.
2. Zalani S, Holley-Guthrie E, Kenney S (1996) Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. Proc Natl Acad Sci USA 93(17):9194-9199.
3. Sun R, et al. (1998) A viral gene that activates lytic cycle expression of Kaposi's sarcoma-Associated herpesvirus. Proc Natl Acad Sci USA 95(18):10866-10871.
4. Kirshner JR, Lukac DM, Chang J, Ganem D (2000) Kaposi's sarcoma-Associated herpesvirus open reading frame 57 encodes a posttranscriptional regulator with multiple distinct activities. J Virol 74(8):3586-3597.
5. Sandri-Goldin RM, Mendoza GE (1992) A herpesvirus regulatory protein appears to act post-Transcriptionally by affecting mRNA processing. Genes Dev 6(5):848-863.
6. Ruvolo V, Wang E, Boyle S, Swaminathan S (1998) The Epstein-Barr virus nuclear protein SM is both a post-Transcriptional inhibitor and activator of gene expression. Proc Natl Acad Sci USA 95(15):8852-8857.
7. Shin YC, Desrosiers RC (2011) Rhesus monkey rhadinovirus ORF57 induces gH and gL glycoprotein expression through posttranscriptional accumulation of target mRNAs. J Virol 85(15):7810-7817.
8. Bilello JP, Morgan JS, Desrosiers RC (2008) Extreme dependence of gH and gL expression on ORF57 and association with highly unusual codon usage in rhesus monkey rhadinovirus. J Virol 82(14):7231-7237.
9. Cochrane AW, Chen CH, Rosen CA (1990) Specific interaction of the human immunodeficiency virus Rev protein with a structured region in the env mRNA. Proc Natl Acad Sci USA 87(3):1198-1202.
10. Malim MH, et al. (1990) HIV-1 structural gene expression requires binding of the Rev trans-Activator to its RNA target sequence. Cell 60(4):675-683.
11. Chang DD, Sharp PA (1989) Regulation by HIV Rev depends upon recognition of splice sites. Cell 59(5):789-795.
12. Lu XB, Heimer J, Rekosh D, Hammarskjöld ML (1990) U1 small nuclear RNA plays a direct role in the formation of a rev-regulated human immunodeficiency virus env mRNA that remains unspliced. Proc Natl Acad Sci USA 87(19):7598-7602.
13. Hammarskjöld ML, et al. (1989) Regulation of human immunodeficiency virus env expression by the rev gene product. J Virol 63(5):1959-1966.
14. Graf M, Ludwig C, Kehlenbeck S, Jungert K, Wagner R (2006) A quasi-lentiviral green fluorescent protein reporter exhibits nuclear export features of late human immunodeficiency virus type 1 transcripts. Virology 352(2):295-305.
15. Bilello JP, et al. (2011) Vaccine protection against simian immunodeficiency virus in monkeys using recombinant gamma-2 herpesvirus. J Virol 85(23):12708-12720.
16. Hansen SG, et al. (2009) Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat Med 15(3):293-299.
17. Hansen SG, et al. (2011) Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 473(7348):523-527.
18. Malim MH, Hauber J, Le SY, Maizel JV, Cullen BR (1989) The HIV-1 rev trans-Activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338(6212):254-257.
19. Shuck-Lee D, Chang H, Sloan EA, Hammarskjold ML, Rekosh D (2011) Single-nucleotide changes in the HIV Rev-response element mediate resistance to compounds that inhibit Rev function. J Virol 85(8):3940-3949.
20. Felber BK, Hadzopoulou-Cladaras M, Cladaras C, Copeland T, Pavlakis GN (1989) rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc Natl Acad Sci USA 86(5):1495-1499.
21. D'Agostino DM, Felber BK, Harrison JE, Pavlakis GN (1992) The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs. Mol Cell Biol 12(3):1375-1386.
22. Perales C, Carrasco L, González ME (2005) Regulation of HIV-1 env mRNA translation by Rev protein. Biochim Biophys Acta 1743(1-2):169-175.
23. Blissenbach M, Grewe B, Hoffmann B, Brandt S, Uberla K (2010) Nuclear RNA export and packaging functions of HIV-1 Rev revisited. J Virol 84(13):6598-6604.
24. Arrigo SJ, Chen IS (1991) Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs. Genes Dev 5(5):808-819.
25. Brandt S, et al. (2007) Rev proteins of human and simian immunodeficiency virus enhance RNA encapsidation. PLoS Pathog 3(4):e54.
26. Groom HC, Anderson EC, Lever AM (2009) Rev: Beyond nuclear export. J Gen Virol 90(Pt 6):1303-1318.
27. Jeang KT (2012) Multi-faceted post-Transcriptional functions of HIV-1 Rev. Biology (Basel) 1(2):165-174.
28. Nekorchuk M, Han Z, Hsieh TT, Swaminathan S (2007) Kaposi's sarcoma-Associated herpesvirus ORF57 protein enhances mRNA accumulation independently of effects on nuclear RNA export. J Virol 81(18):9990-9998.
29. Pilkington GR, et al. (2012) Kaposi's sarcoma-Associated herpesvirus ORF57 is not a bona fide export factor. J Virol 86(23):13089-13094.
30. Malik P, Blackbourn DJ, Clements JB (2004) The evolutionarily conserved Kaposi's sarcoma-Associated herpesvirus ORF57 protein interacts with REF protein and acts as an RNA export factor. J Biol Chem 279(31):33001-33011.
31. Williams BJ, et al. (2005) The prototype gamma-2 herpesvirus nucleocytoplasmic shuttling protein, ORF 57, transports viral RNA through the cellular mRNA export pathway. Biochem J 387(Pt 2):295-308.
32. Presnyak V, et al. (2015) Codon optimality is a major determinant of mRNA stability. Cell 160(6):1111-1124.
33. Nackley AG, et al. (2006) Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 314(5807):1930-1933.
34. Kudla G, Murray AW, Tollervey D, Plotkin JB (2009) Coding-sequence determinants of gene expression in Escherichia coli. Science 324(5924):255-258.
35. Kimchi-Sarfaty C, et al. (2007) A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 315(5811):525-528.
36. Zhou M, et al. (2013) Non-optimal codon usage affects expression, structure and function of clock protein FRQ. Nature 495(7439):111-115.
37. Schneider R, Campbell M, Nasioulas G, Felber BK, Pavlakis GN (1997) Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation. J Virol 71(7):4892-4903.
38. Barreau C, Paillard L, Osborne HB (2005) AU-rich elements and associated factors: Are there unifying principles? Nucleic Acids Res 33(22):7138-7150.
39. Megati S, et al. (2008) Modifying the HIV-1 env gp160 gene to improve pDNA vaccineelicited cell-mediated immune responses. Vaccine 26(40):5083-5094.
40. Fuhrmann M, et al. (2004) Monitoring dynamic expression of nuclear genes in Chlamydomonas reinhardtii by using a synthetic luciferase reporter gene. PlantMol Biol 55(6):869-881.
41. Gribskov M, Devereux J, Burgess RR (1984) The codon preference plot: Graphic analysis of protein coding sequences and prediction of gene expression. Nucleic Acids Res 12(1 Pt 2):539-549.
42. Grote A, et al. (2005) JCat: A novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res 33(Web Server issue):W526-W531.
43. Hofacker IL (2003) Vienna RNA secondary structure server. Nucleic Acids Res 31(13):3429-3431.
44. Bilello JP, Morgan JS, Damania B, Lang SM, Desrosiers RC (2006) A genetic system for rhesus monkey rhadinovirus: Use of recombinant virus to quantitate antibody-mediated neutralization. J Virol 80(3):1549-1562.
45. Montefiori DC (2009) Measuring HIV neutralization in a luciferase reporter gene assay. Methods Mol Biol 485:395-405.
46. Naranatt PP, Akula SM, Chandran B (2002) Characterization of gamma2-human herpesvirus-8 glycoproteins gH and gL. Arch Virol 147(7):1349-1370.
47. Zuker M, Stiegler P (1981) Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information. Nucleic Acids Res 9(1):133-148.